Eastern Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.13M | Sell |
88,290
-9,490
| -10% | -$248K | 0.03% | 156 |
|
|
2026
Q1 | $2.75M | Sell |
97,780
-1,881
| -2% | -$50.1K | 0.05% | 147 |
|
|
2025
Q4 | $2.48M | Sell |
99,661
-945
| -0.9% | -$23.8K | 0.04% | 137 |
|
|
2025
Q3 | $2.56M | Buy |
100,606
+8,695
| +9% | +$215K | 0.05% | 130 |
|
|
2025
Q2 | $2.23M | Sell |
91,911
-4,973
| -5% | -$116K | 0.04% | 141 |
|
|
2025
Q1 | $2.46M | Sell |
96,884
-455
| -0.5% | -$11.9K | 0.05% | 137 |
|
|
2024
Q4 | $2.58M | Sell |
97,339
-10,127
| -9% | -$275K | 0.05% | 149 |
|
|
2024
Q3 | $3.11M | Buy |
107,466
+88,982
| +481% | +$2.6M | 0.06% | 154 |
|
|
2024
Q2 | $517K | Sell |
18,484
-2,641
| -13% | -$72.7K | 0.02% | 151 |
|
|
2024
Q1 | $586K | Sell |
21,125
-2,219
| -10% | -$61.6K | 0.02% | 152 |
|
|
2023
Q4 | $672K | Sell |
23,344
-687
| -3% | -$20.8K | 0.03% | 148 |
|
|
2023
Q3 | $797K | Sell |
24,031
-50
| -0.2% | -$1.77K | 0.04% | 135 |
|
|
2023
Q2 | $883K | Sell |
24,081
-1,822
| -7% | -$70.9K | 0.04% | 132 |
|
|
2023
Q1 | $1.06M | Sell |
25,903
-62,613
| -71% | -$2.7M | 0.05% | 127 |
|
|
2022
Q4 | $4.54M | Sell |
88,516
-3,425
| -4% | -$164K | 0.24% | 80 |
|
|
2022
Q3 | $4.02M | Sell |
91,941
-10,667
| -10% | -$518K | 0.23% | 85 |
|
|
2022
Q2 | $5.38M | Sell |
102,608
-20,453
| -17% | -$1.04M | 0.29% | 78 |
|
|
2022
Q1 | $6.37M | Sell |
123,061
-16,396
| -12% | -$851K | 0.3% | 74 |
|
|
2021
Q4 | $8.23M | Sell |
139,457
-378
| -0.3% | -$18.7K | 0.36% | 72 |
|
|
2021
Q3 | $6.01M | Buy |
139,835
+3,604
| +3% | +$160K | 0.29% | 76 |
|
|
2021
Q2 | $5.33M | Buy |
136,231
+459
| +0.3% | +$17.8K | 0.26% | 79 |
|
|
2021
Q1 | $4.92M | Sell |
135,772
-9,321
| -6% | -$331K | 0.27% | 79 |
|
|
2020
Q4 | $5.34M | Sell |
145,093
-5,850
| -4% | -$215K | 0.3% | 70 |
|
|
2020
Q3 | $5.26M | Buy |
150,943
+7,105
| +5% | +$249K | 0.32% | 70 |
|
|
2020
Q2 | $4.46M | Sell |
143,838
-72
| -0.1% | -$2.45K | 0.29% | 72 |
|
|
2020
Q1 | $4.46M | Sell |
143,910
-3,529
| -2% | -$120K | 0.33% | 69 |
|
|
2019
Q4 | $5.48M | Sell |
147,439
-8,013
| -5% | -$285K | 0.32% | 68 |
|
|
2019
Q3 | $5.3M | Buy |
155,452
+23,893
| +18% | +$869K | 0.33% | 68 |
|
|
2019
Q2 | $5.41M | Sell |
131,559
-4,060
| -3% | -$161K | 0.34% | 69 |
|
|
2019
Q1 | $5.46M | Buy |
135,619
+1,417
| +1% | +$56.7K | 0.37% | 70 |
|
|
2018
Q4 | $5.56M | Sell |
134,202
-1,545
| -1% | -$64.1K | 0.42% | 72 |
|
|
2018
Q3 | $5.68M | Sell |
135,747
-5,835
| -4% | -$225K | 0.37% | 77 |
|
|
2018
Q2 | $4.87M | Sell |
141,582
-13,864
| -9% | -$474K | 0.33% | 78 |
|
|
2018
Q1 | $5.23M | Buy |
155,446
+3,435
| +2% | +$118K | 0.37% | 77 |
|
|
2017
Q4 | $5.22M | Sell |
152,011
-2,150
| -1% | -$73.3K | 0.35% | 78 |
|
|
2017
Q3 | $5.22M | Sell |
154,161
-77
| -0% | -$2.48K | 0.37% | 79 |
|
|
2017
Q2 | $4.92M | Buy |
154,238
+2,075
| +1% | +$65.4K | 0.36% | 79 |
|
|
2017
Q1 | $4.94M | Sell |
152,163
-3,707
| -2% | -$117K | 0.37% | 79 |
|
|
2016
Q4 | $4.8M | Buy |
155,870
+1,880
| +1% | +$57.4K | 0.37% | 76 |
|
|
2016
Q3 | $4.95M | Buy |
153,990
+86,172
| +127% | +$2.88M | 0.4% | 76 |
|
|
2016
Q2 | $2.27M | Sell |
67,818
-225
| -0.3% | -$7.18K | 0.18% | 93 |
|
|
2016
Q1 | $1.91M | Sell |
68,043
-749
| -1% | -$21.4K | 0.16% | 98 |
|
|
2015
Q4 | $2.11M | Buy |
68,792
+440
| +0.6% | +$13.8K | 0.18% | 89 |
|
|
2015
Q3 | $2.04M | Buy |
68,352
+2,559
| +4% | +$82K | 0.18% | 92 |
|
|
2015
Q2 | $2.09M | Sell |
65,793
-3,720
| -5% | -$121K | 0.17% | 89 |
|
|
2015
Q1 | $2.29M | Sell |
69,513
-2,313
| -3% | -$73.5K | 0.18% | 90 |
|
|
2014
Q4 | $2.12M | Sell |
71,826
-108
| -0.2% | -$3.1K | 0.17% | 90 |
|
|
2014
Q3 | $2.02M | Sell |
71,934
-10,448
| -13% | -$293K | 0.16% | 94 |
|
|
2014
Q2 | $2.32M | Sell |
82,382
-82,465
| -50% | -$2.35M | 0.19% | 83 |
|
|
2014
Q1 | $5.02M | Buy |
164,847
+6,324
| +4% | +$189K | 0.42% | 68 |
|
|
2013
Q4 | $4.61M | Buy |
158,523
+4,315
| +3% | +$126K | 0.39% | 68 |
|
|
2013
Q3 | $4.2M | Buy |
154,208
+5,528
| +4% | +$150K | 0.39% | 68 |
|
|
2013
Q2 | $3.95M | Buy |
+148,680
| New | +$4.11M | 0.37% | 68 |
|
Other funds holding PFE
Eastern Bank's PFE Position: Q2 2026 in Review
Eastern Bank reduced its Pfizer (PFE) stake by 9.7% in Q2 2026, selling an estimated $248K and leaving 88,290 shares worth $2.13M. The position accounts for 0.03% of the portfolio, ranked #156.
Eastern Bank first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.23M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Eastern Bank held 88,290 shares of Pfizer worth $2.13M as of Q2 2026.
- Eastern Bank sold 9,490 Pfizer shares in Q2 2026, an estimated $248K.
- Pfizer made up 0.03% of Eastern Bank's portfolio in Q2 2026, its #156 holding.
- Eastern Bank first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Eastern Bank's Pfizer position peaked at $8.23M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.